Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Melanoma Research|October 13, 2012
Outcome following local recurrence or in-transit metastases in cutaneous melanomaNora J Suojärvi, Tiina A Jahkola, Susanna Virolainen, et al.
Virchows Archiv : an International Journal of Pathology|September 1, 2005
MMP-21 is upregulated at early stages of melanoma progression but disappears with more aggressive phenotypeTiina Kuivanen, Katja Ahokas, Susanna Virolainen, et al.
Plos One|September 1, 2009
Expression of antizyme inhibitor 2 in mast cells and role of polyamines as selective regulators of serotonin secretionKristiina Kanerva, Jani Lappalainen, Laura T Mäkitie, et al.
Human Pathology|December 3, 2014
Prospective immunohistochemical analysis of BRAF V600E mutation in melanomaAlexandra Thiel, Monica Moza, Soili Kytölä, et al.
Oncotarget|February 27, 2016
Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progressionJohanna Eriksson, Vadim Le Joncour, Pirjo Nummela, et al.
Science Translational Medicine|February 11, 2011
Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasisTuomas Tammela, Anne Saaristo, Tanja Holopainen, et al.
Experimental Dermatology|July 16, 2009
MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancerSonja Boyd, Susanna Virolainen, Jenita Pärssinen, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|February 21, 2015
MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomasAbdirisak Ahmed Haji Omar, Caj Haglund, Susanna Virolainen, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|January 3, 2013
Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomasAbdirisak Ahmed Haji Omar, Caj Haglund, Susanna Virolainen, et al.
Pageof 3